Challenging AbbVie and Lilly in psoriatic arthritis, J&J touts 2-year data for Tremfya

Challenging AbbVie and Lilly in psoriatic arthritis, J&J touts 2-year data for Tremfya
esagonowsky
Tue, 03/16/2021 – 11:03